New Business Models in Healthcare Roundtable
Programme :
6.00 pm - Welcome
6.30 pm - Roundtable
7.30 pm - Apero & Networking
E-health is booming thanks to recent technological advances driven by the availability of fast, reliable, and ubiquitous communication networks, as well as by the development of new algorithmic approaches. At the same time there is growing awareness of the need for virtual solutions to help tackle the explosive rise in healthcare costs, particularly after the Covid-19 pandemic.
While all the elements necessary to accelerate this transition are present, companies are still struggling to identify the ideal business model. How can they monetise new services and the data they have collected? What type of relationship should they establish with patients users/customers? How can they integrate these changes into existing workflows while making them more effective and efficient? We will be discussing these and other questions with experts from established e-health companies, innovative startups, and VC firms investing in the companies of tomorrow.
Speakers :
 | Charity Kufaas Vice President, Care model Innovation, NOK and Diabeter, Global Regions, Medtronic With over 12 years of experience in medical devices and equipment at Medtronic and GE Healthcare, as well as a decade in corporate finance, Charity has a solid track record in identifying and implementing on profitable business growth opportunities in the healthcare industry. |
 | Marylin Mermod Schule CEO, Swiss Safe Collect Marylin has 25 years' experience as a Director/CFO/COO of technology scale-ups and fast-growing SMEs in technology, genomics, and health diagnostics. She currently leads Swiss Safe Collect, which has developed a solution to measure and follow 14 urine biomarkers for personalized predictive health. |
 | Esmeralda Megally CEO & Co-Founder, Xsensio Esmeralda is the CEO of Xsensio, a company she co-founded, in 2014 which has developed at EPFL’s nanolab, a highly-miniaturized sensing platform to sense in real-time biochemical information at the surface of the skin. Prior to Xsensio, Esmeralda spent several years as manager at Boston-based investment firm Commons Capital. She earned her MBA at the Massachusetts Institute of Technology (MIT), a B.S. and M.S. in Economics from ULB, Belgium and an executive degree in management from EPFL. |
 | Diego Braguglia Managing Partner, VI Partners Over more than two decades in venture capital, Diego has developed broad expertise in creating, growing and exiting ventures in therapeutics and medical devices. He has served on the board of a dozen companies, including Sequana Medical and Endosense. |
Where ?
EPFL Campus, Room BC 420, 1015 Lausanne
Event organizers :
INSEAD in collaboration with EPFL Alumni
Team EPFL Alumni